FDA Approves MS and Cancer Drugs
59092
The FDA, which has been under criticism for its lengthy approval process, this week approved two new drugs for multiple sclerosis and cancer treatment.
486729
U.S. health regulators have approved  GlaxoSmithKline Plc&#39;s   pill Tykerb for patients  with advanced breast cancer after other treatments have failed,  a company spokeswoman said on Tuesday.
371520
Biogen Idec Inc. won federal approval for its new anti-multiple sclerosis drug Antegren - the first new treatment for MS patients in eight years.
416254
CAMBRIDGE, Massachusetts The drug Clolar has won Food and Drug Administration approval to treat patients ages one to 21 who have exhausted other treatment options for acute lymphoblastic leukemia.
729539
WASHINGTON - The Food and Drug Administration yesterday gained broad new powers to ensure the safety of prescription drugs used by millions of Americans under a bill signed by President Bush.
208946
The Food and Drug Administration agreed Friday to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
133355
Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.
671018
Thalidomide received federal approval Thursday for treatment of bone-marrow cancer, marking the further rehabilitation of a drug originally banned more than 40 years ago after it caused thousands of birth defects.
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
256613
(letrozole) is the first therapy approved by theU.S. Food and Drug Administration (FDA) for the extended adjuvant treatmentof postmenopausal women with early breast cancer who have received adjuvant(post-surgery) tamoxifen therapy for five years
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
440572
The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
758408
WASHINGTON -- The Food and Drug Administration on Wednesday approved a widely used adult psychiatric drug for the treatment of schizophrenia and bipolar disorder in children and adolescents.